— Perrigo Company plc (NYSE: PRGO) reported Q3 2019 earnings of $1.04 per share, vs. $0.93 expected.
— Sales grew 5.1% to $1.2 billion, vs. $1.2 billion expected.
— Worldwide Consumer net sales increased 3.3% to $961 million.
— Prescription Pharmaceuticals sales improved 13.6% to $230 million.
— FY19 GAAP EPS is expected to be $2.01-2.21.
— FY19 adjusted EPS is expected to be $3.85-4.05.
— PRGO shares gained 0.98% following the announcement.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Micron Technology (MU) Q3 Earnings: Key financials and quarterly highlights
Micron Technology Inc. (NASDAQ: MU) reported third quarter 2022 earnings results today. Revenue increased 16% year-over-year to $8.64 billion. GAAP net income was $2.63 billion, or $2.34 per share, compared
Constellation Brands (STZ): Earnings beat and share structure revamp put brewer in the spotlight
Shares of Constellation Brands Inc. (NYSE: STZ) were down 4% on Thursday despite the company beating expectations on its first quarter 2023 earnings results. The stock has dropped 7% year-to-date.
Infographic: Key highlights from Constellation Brands (STZ) Q1 2023 earnings results
Constellation Brands, Inc. (NYSE: STZ) reported first quarter 2023 earnings results today. Net sales increased 17% year-over-year to $2.3 billion. Net income attributable to CBI was $390 million, or $2.06
